ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An Autophagy-Related Gene Signature can Better Predict Prognosis and Resistance in Diffuse Large B-Cell Lymphoma

Zhou, Xuan; He, Ying-Zhi; Liu, Dan; Lin, Chao-Ran; Liang, Dan; Huang, Rui*; Wang, Liang*广东医学院; 南方医科大学; 1
Frontiers in Genetics2022-6-30DOI: 10.3389/fgene.2022.862179
2被引9阅读
引用收藏
分享

摘要

Background: Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous disease, and about 30%-40% of patients will develop relapsed/refractory DLBCL. In this study, we aimed to develop a gene signature to predict survival outcomes of DLBCL patients based on the autophagy-related genes (ARGs).Methods: We sequentially used the univariate, least absolute shrinkage and selector operation (LASSO), and multivariate Cox regression analyses to build a gene signature. The Kaplan-Meier curve and the area under the receiver operating characteristic curve (AUC) were performed to estimate the prognostic capability of the gene signature. GSEA analysis, ESTIMATE and ssGSEA algorithms, and one-class logistic regression were performed to analyze differences in pathways, immune response, and tumor stemness between the high- and low-risk groups.Results: Both in the training cohort and validation cohorts, high-risk patients had inferior overall survival compared with low-risk patients. The nomogram consisted of the autophagy-related gene signature, and clinical factors had better discrimination of survival outcomes, and it also had a favorable consistency between the predicted and actual survival. GSEA analysis found that patients in the high-risk group were associated with the activation of doxorubicin resistance, NF-kappa B, cell cycle, and DNA replication pathways. The results of ESTIMATE, ssGSEA, and mRNAsi showed that the high-risk group exhibited lower immune cell infiltration and immune activation responses and had higher similarity to cancer stem cells.Conclusion: We proposed a novel and reliable autophagy-related gene signature that was capable of predicting the survival and resistance of patients with DLBCL and could guide individualized treatment in future.

学科与关键词

关键词
diffuse large B-cell lymphomaautophagy-related genesgene signatureprognosisautophagy inhibitors
相关
加载中…
  • A Novel Six Autophagy-Related Genes Signature Associated With Outcomes and Immune Microenvironment in Lower-Grade Glioma
    Lin, Tao; Cheng, Hao; Liu, Da; Wen, Lei; Kang, Junlin; Xu, Longwen; Shan, Changguo; Chen, Zhijie; Li, Hainan; Lai, Mingyao; Zhou, Zhaoming; Hong, Weiping; Hu, Qingjun; Li, Shaoqun; Zhou, Cheng; Geng, Jiwu*; Jin, Xin*Frontiers in Genetics, 2021, 12: 698284.被引 10
  • An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment
    Liang, Xiao-Jie; Fu, Rui-ying; Wang, He-nan; Yang, Jing; Yao, Na; Liu, Xin-di; Wang, Liang*Journal of Immunology Research, 2021, 2021: 5564568.被引 7
  • Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on ferroptosis-related genes and its association with immune infiltration
    Xiong, Dan*; Li, Mojuan; Zeng, Chong*Translational Oncology, 2022, 16: 101314.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-06-30
卷期
第 13 卷
页码
862179
DOI
10.3389/fgene.2022.862179
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81873450]

作者

  • Z

    Zhou, Xuan (第一作者)

    1 · fujian med univ · 2 · southern med univ

  • H

    He, Ying-Zhi

    southern med univ

查看全部 7 位作者收起作者
  • L

    Liu, Dan

    1 · guangdong med univ

  • L

    Lin, Chao-Ran

    1 · guangdong med univ

  • L

    Liang, Dan

    2 · southern med univ

  • H

    Huang, Rui (通讯)

    southern med univ

  • W

    Wang, Liang (通讯)

    capital med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417